Brief: Mayne Pharma Posts H1 Gross Margin 65.3%
23/02/2026 02:09
Feb 23 (Reuters) - Mayne Pharma Group Ltd MYX.AX: H1 GROSS MARGIN 65.3% WILL CONTINUE TO PURSUE SCALE ACROSS PORTFOLIO, OTHERS, WHICH MAY INCLUDE A SHARE BUY-BACK Further company coverage: MYX.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mayne Pharma
See all newsBrief: Mayne Pharma Group Says It Settles Us Patent Litigation Re Imvexxy With Teva USA
Deals of the day-Mergers and acquisitions
Brief: Mayne Pharma Says Supreme Court Dismisses Cosette Appeal
Deals of the day-Mergers and acquisitions
Australian court dismisses Cosette appeal to drop Mayne Pharma takeover (updated)